title: [Efficacity of rituximab in hemolytic anemia with cold autoantibodies case].
abstract: BACKGROUND
  Autoimmune hemolytic anemia with cold autoantibodies or cold agglutinin disease is a rare chronic disorder in which no treatment has, until now, evidence of its effectiveness.
  
  
  METHODS
  We report a patient who successfully responded to rituximab for a cold agglutinin disease refractory to conventional therapy with very good tolerance and a complete remission.
  
  
  CONCLUSIONS
  There are only few observations that have been reported in the literature regarding the efficacity of rituximab in the treatment of cold agglutinin disease. This promising therapy could, in the future, constitute a real alternative.
authors.affiliation: Département de médecine interne B, hôpital militaire d'instruction, Med-V, Rabat, Maroc. sekkach@hotmail.com
authors.forename: Y
authors.initials: Y
authors.lastname: Sekkach
authors.forename: S
authors.initials: S
authors.lastname: Hammi
authors.forename: M
authors.initials: M
authors.lastname: Elqatni
authors.forename: J
authors.initials: J
authors.lastname: Fatihi
authors.forename: N
authors.initials: N
authors.lastname: Elomri
authors.forename: F
authors.initials: F
authors.lastname: Mekouar
authors.forename: M
authors.initials: M
authors.lastname: Badaoui
authors.forename: M
authors.initials: M
authors.lastname: Jira
authors.forename: J
authors.initials: J
authors.lastname: Smaali
authors.forename: A
authors.initials: A
authors.lastname: El Khattabi
authors.forename: T
authors.initials: T
authors.lastname: Amezyane
authors.forename: A
authors.initials: A
authors.lastname: Abouzahir
authors.forename: D
authors.initials: D
authors.lastname: Ghafir
mesh_terms: D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy*; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004351:Drug Resistance; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab